Scarica l'app Stockscreener
134.44
0.72%
1.27
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$133.17
Aprire:
$132.41
Volume 24 ore:
852.88K
Relative Volume:
0.16
Capitalizzazione di mercato:
$230.98B
Reddito:
$41.95B
Utile/perdita netta:
$13.40B
Rapporto P/E:
17.57
EPS:
7.65
Flusso di cassa netto:
$6.49B
1 W Prestazione:
+2.70%
1M Prestazione:
+14.85%
6M Prestazione:
+20.41%
1 anno Prestazione:
+13.79%
Intervallo 1D:
$132.41
$134.33
Intervallo di 1 settimana:
$128.25
$134.33
Portata 52W:
$99.71
$134.33
Abbott Laboratories Stock (ABT) Company Profile
Nome
Abbott Laboratories
Settore
Industria
Telefono
(224) 667-6100
Indirizzo
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Confronta ABT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABT
Abbott Laboratories
|
134.31 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.52 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
386.55 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.86 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
74.12 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Abbott Laboratories Stock (ABT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-08 | Iniziato | Oppenheimer | Outperform |
| 2024-09-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-30 | Downgrade | Edward Jones | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2023-07-21 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2023-05-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-04-20 | Reiterato | Barclays | Overweight |
| 2023-04-20 | Reiterato | Bernstein | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Raymond James | Outperform |
| 2023-04-20 | Reiterato | UBS | Buy |
| 2023-04-20 | Reiterato | Wolfe Research | Underperform |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-10-26 | Iniziato | Mizuho | Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-27 | Reiterato | Credit Suisse | Outperform |
| 2022-01-27 | Reiterato | Morgan Stanley | Overweight |
| 2022-01-27 | Reiterato | Raymond James | Outperform |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-27 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Neutral |
| 2021-01-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-06-01 | Downgrade | Goldman | Neutral → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Neutral |
| 2020-01-02 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-02-07 | Reiterato | BofA/Merrill | Buy |
| 2019-01-02 | Downgrade | Citigroup | Neutral → Sell |
| 2018-11-30 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-01-30 | Reiterato | Citigroup | Neutral |
| 2018-01-25 | Reiterato | Stifel | Buy |
| 2018-01-25 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-01-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2017-10-19 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-10-19 | Reiterato | Stifel | Buy |
Mostra tutto
Abbott Laboratories Borsa (ABT) Ultime notizie
Point of Care Diagnostic Market to grow at a CAGR of 7.5% (2024 – 2030): Wissen Research - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Shares Sold by Paradigm Asset Management Co. LLC - MarketBeat
Glucose Biosensor Market to Witness Remarkable Growth with Abbott Laboratories, Dexcom, F. Hoffmann-La Roche - EIN News
Bradley Foster & Sargent Inc. CT Grows Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Cordatus Wealth Management LLC Acquires Shares of 23,574 Abbott Laboratories (NYSE:ABT) - MarketBeat
Nicholson Wealth Management Group LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Principal Securities Inc. Acquires 8,389 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Meitav Investment House Ltd. Reduces Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Advyzon Investment Management LLC Acquires New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Americana Partners LLC Sells 2,006 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
D.A. Davidson & CO. Increases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Strategic Financial Concepts LLC Takes $316,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Lateral Flow Assay Market Top PlayersAbbott Laboratories - openPR
Kornitzer Capital Management Inc. KS Purchases 9,314 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Ramsay Stattman Vela & Price Inc. Purchases 6,346 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Abbott Laboratories (NYSE:ABT) Reaches New 52-Week HighHere's Why - MarketBeat
ING Groep NV Sells 99,117 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Boston Financial Mangement LLC Decreases Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Parcion Private Wealth LLC Buys 2,161 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Handelsbanken Fonder AB Reduces Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Ieq Capital LLC Raises Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
Corps Capital Advisors LLC Takes Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Bioelectric Medicine Market Key Players AnalysisAbbott - openPR
bLong Financial LLC Buys New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Private Advisor Group LLC Acquires 90,662 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Alberta Investment Management Corp Purchases 80,435 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Global Retirement Partners LLC Has $6.63 Million Stake in Abbott Laboratories (NYSE:ABT) - MarketBeat
DSM Capital Partners LLC Acquires 370,049 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Atlas Legacy Advisors LLC Acquires New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Holdings Boosted by Atria Wealth Solutions Inc. - MarketBeat
Bank of Jackson Hole Trust Purchases New Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
10,812 Shares in Abbott Laboratories (NYSE:ABT) Purchased by GAM Holding AG - MarketBeat
MOKAN Wealth Management Inc. Makes New $2.36 Million Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories - Yahoo Finance
Callahan Advisors LLC Buys 10,022 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat
Buckingham Capital Management Inc. Sells 24,982 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Holdings Lifted by Venturi Wealth Management LLC - MarketBeat
Diabetic Retinopathy Market Projected To Witness Substantial Growth 2025-2032:Abbott Laboratories, Novartis - EIN News
Abbott Laboratories (NYSE:ABT) Hits New 1-Year HighWhat's Next? - MarketBeat
Medical Nutrition Market Top Players- Abbott Laboratories; Pfizer Inc.; Bayer AG; Nestle S.A.; GlaxoSmithKline plc. - openPR
Sawgrass Asset Management LLC Cuts Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Attessa Capital LLC Takes $295,000 Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Rhumbline Advisers Sells 28,139 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
WealthPLAN Partners LLC Reduces Stock Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stake Boosted by Campbell Wealth Management - MarketBeat
First Merchants Corp Lowers Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Stock Position Trimmed by Vontobel Holding Ltd. - MarketBeat
BXM Wealth LLC Acquires Shares of 3,269 Abbott Laboratories (NYSE:ABT) - MarketBeat
Stanley Laman Group Ltd. Sells 4,927 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories Azioni (ABT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):